Targeting the Bone Marrow
microenvironment
for augmentation of normal hematopoiesis
and treatment of leukemia
Our focus
Building on years of our research, we focus on the following two indications:
HSC Expansion
Expansion of hematopoietic stem cells (HSCs) from umbilical cord blood or other sources for HSC transplantation for various diseases
Leukemia treatment
Design and testing of inhibitors of the integrin signaling pathway for the treatment of leukemia
HSC expansion
Expansion of hematopoietic stem cells (HSCs) from umbilical cord blood or other sources for HSC transplantation for various diseases
leukemia treatment
Design and testing of inhibitors of the integrin signaling pathway for the treatment of leukemia
Daniela Krause, MD, PhD
Professor
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Goethe University Frankfurt, Germany
Keertik Fulzele, PhD
Cancer Center,
Massachusetts General Hospital,
Harvard Medical School, Boston, MA
Massachusetts General Hospital,
Harvard Medical School, Boston, MA
Contact Us
Contact us for additional information.
Contact us
info@myelox.com